Acute respiratory distress syndrome is a leading cause of respiratory failure after surgery.
Patients who develop the lung disorder postoperatively are at higher risk of dying in the hospital, and those who survive the syndrome may still bear its physical effects years later.
A Mayo Clinic-led study is helping physicians better identify patients most at risk, the first step toward preventing this dangerous and costly surgical complication. They found nine independent risk factors, including sepsis, high-risk aortic vascular surgery, high-risk cardiac surgery, emergency surgery, cirrhosis of the liver, and admission to the hospital from a location other than home, such as a nursing home.
The findings are published in the journal Anesthesiology.
"This is a very common reason for needing an extended course of breathing support after surgery, and approximately 20 to 25 percent of patients who develop the syndrome will die from it," says first author Daryl Kor, M.D., a Mayo Clinic anesthesiologist. "It's well-documented that those who develop this syndrome stay in intensive care longer and in the hospital longer, and the impact of the syndrome can persist for many years."
Prevention of acute respiratory distress syndrome has become a priority for the National Institutes of Health's National Heart, Lung, and Blood Institute, the researchers noted.
To help prevent the condition, physicians first must identify who is most at risk, and that has proved difficult to do with individual patients, the researchers say. They studied 1,562 surgical patients considered at high risk of developing the syndrome, and found:
The findings may alter the way patients at high risk of the syndrome are cared for in the operating room, Dr. Kor says.
"For example, we may be a bit more conservative in the way we transfuse blood products. We may also ventilate their lungs in a little different way than we might if their risk score was low," Dr. Kor says. "We also hope that by identifying these high-risk patients, we might be able to better select a study population for future studies that look at specific prevention strategies. Before, such studies really weren't feasible because we couldn't identify high-risk groups with any degree of accuracy."
Future research may include studying the specific role that anesthetic care plays and whether aspects of care in the operating room should be modified in patients at high risk of developing the syndrome, Dr. Kor says.
Study co-authors included physicians and researchers from Mayo Clinic in Rochester and Jacksonville, Fla., and from Beth Israel Deaconess Medical Center, Albert Einstein College of Medicine, University of Texas Southwestern Medical Center, Duke University Medical Center, Massachusetts General Hospital, Wake Forest University Health Sciences, Brigham and Women's Hospital, University of Michigan School of Medicine and St. Joseph Mercy Hospital. The NIH-funded United States Critical Illness and Injury Trials Group collaborated on the study.
The study was supported by a career development grant from the Foundation for Anesthesia Education and Research in Rochester; by National Institutes of Health grants U01-HL108712-01, UL1 TR000135 and KL2 TR000136; and by the Mayo Clinic Critical Care Research Committee.
About Mayo Clinic
Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit 150years.mayoclinic.org, MayoClinic.org or http://newsnetwork.mayoclinic.org/.
MEDIA CONTACT: Sharon Theimer, Mayo Clinic Public Affairs, 507-284-5005, Email: email@example.com
Sharon Theimer | Eurek Alert!
NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases
Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
19.03.2018 | Physics and Astronomy
19.03.2018 | Materials Sciences
19.03.2018 | Event News